Bernard Regnier

9.5k citations

156 papers · 7.4k · 2 hit papers · h-index 48

Impact in

Critical Care and Intensive Care Medicine top 0.5%
- Nosocomial Infections in ICU
Applied Microbiology and Biotechnology top 1%
- Antibiotic Use and Resistance

Papers in

Infectious Diseases 36
- Infection Control in Healthcare 11
- Antifungal resistance and susceptibility 9
Critical Care and Intensive Care Medicine 17
- Nosocomial Infections in ICU 11

Co-authors: Michel Wolff (63 shared papers)Sylvie Chevret (8 shared papers)Lila Bouadma (12 shared papers)Jean M. Carlet (14 shared papers)Bertrand Gachot (14 shared papers)Jean‐François Timsit (11 shared papers)Jean‐Christophe Lucet (9 shared papers)Benoît Veber (6 shared papers)
Journals: Intensive Care Medicine (25 papers)The Lancet (9 papers)Clinical Infectious Diseases (7 papers)Critical Care Medicine (6 papers)Antimicrobial Agents and Chemotherapy (4 papers)
Partner nations: France United Kingdom Spain

In The Last Decade

Bernard Regnier

148 papers receiving 6.8k citations

Bernard Regnier's Hit Papers

align trajectories log scale

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial 2010 · 944 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2010 The Lancet
2009 Critical Care Medicine

Peers

Countries citing papers authored by Bernard Regnier

Since Specialization

Citations

This map shows the geographic impact of Bernard Regnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Regnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Regnier more than expected).

Fields of papers citing papers by Bernard Regnier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Regnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Regnier. The network helps show where Bernard Regnier may publish in the future.

Co-authors

The 25 scholars most cited alongside Bernard Regnier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bernard Regnier Line = papers co-authored together Bernard Regnier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 156 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial The Lancet ·Lila Bouadma, Charles‐Édouard Luyt, Florence Tubach, Christophe Cracco, Antonio Alvarez, Carole Schwebel, Frédérique Schortgen, Sigismond Lasocki Hit paper breakdown →	2010	944
2	Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006) Critical Care Medicine ·Olivier Leroy, Jean‐Pierre Gangneux, Philippe Montravers, Jean‐Paul Mira, Jean-Pierre Sollet, Jean M. Carlet, Jacques Reynes, M. Rosenheim Hit paper breakdown →	2009	439
3	Attributable Morbidity and Mortality of Catheter-Related Septicemia in Critically Ill Patients: a Matched, Risk-Adjusted, Cohort Study Infection Control and Hospital Epidemiology ·Lilia Soufir, Jean‐François Timsit, Cédric Mahé, Jean M. Carlet, Bernard Regnier, Sylvie Chevret	1999	256
4	Discrepancies between Perceptions by Physicians and Nursing Staff of Intensive Care Unit End-of-Life Decisions American Journal of Respiratory and Critical Care Medicine ·Édouard Ferrand, François Lemaire, Bernard Regnier, Khaldoun Kuteifan, Michel Badet, Pierre Asfar, Samir Jaber, J.L. Chagnon	2003	244
5	Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome The American Journal of Medicine ·Catherine Leport, François Raffi, Sophie Matheron, Christine Katlama, Bernard Regnier, A. G. Saimot, Claudie Marche, Claude Vedrenne	1988	217
6	Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: Impact of previous antimicrobial treatments Critical Care Medicine ·Bertrand Souweine, Benoît Veber, Jean Pierre Bedos, Bertrand Gachot, Marie Christine Dombret, Bernard Regnier, Michel Wolff	1998	188
7	Outbreak of Multiply Resistant Enterobacteriaceae in an Intensive Care Unit: Epidemiology and Risk Factors for Acquisition Clinical Infectious Diseases ·Jean Christophe Lucet, Sylvie Chevret, Dominique Decré, Dominique Vanjak, Annick Macrez, Jean Pierre Bedos, Michel Wolff, Bernard Regnier	1996	175
8	The Clinical Spectrum of Severe Imported Falciparum Malaria in the Intensive Care Unit: Report of 188 Cases in Adults American Journal of Respiratory and Critical Care Medicine ·Fabrice Bruneel, Laurent Hocqueloux, Corinne Alberti, Michel Wolff, Sylvie Chevret, Jean‐Pierre Bédos, Rémy Durand, Jacques Le Bras	2003	163
9	EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX The Lancet ·Eric Dournon, Willy Rozenbaum, Christophe Michon, Christian Perronne, P. de Truchis, Élisabeth Bouvet, Maryse Levacher, Sophie Matheron	1988	156
10	Control of a Prolonged Outbreak of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a University Hospital Clinical Infectious Diseases ·Jean‐Christophe Lucet, Dominique Decré, Anika Fichelle, Marie‐Laure Joly‐Guillou, Micheline Pernet, Claude Deblangy, Marie-Jeanne Kosmann, Bernard Regnier	1999	150
11	Epidemiological Features of and Risk Factors for Infection by Streptococcus pneumoniae Strains with Diminished Susceptibility to Penicillin: Findings of a French Survey Clinical Infectious Diseases ·Jean Pierre Bedos, Sylvie Chevret, Claude Chastang, P. Geslin, Bernard Regnier +1 other	1996	136
12	In Vivo Selection of a Cephamycin-Resistant, Porin-Deficient Mutant of Klebsiello pneumoniae Producing a TEM-3 -Lactamase The Journal of Infectious Diseases ·B. Pangon, Chantal Bizet, A Buré, F. Pichon, A. Philippon, Bernard Regnier, Laurent Gutmann	1989	127
13	Prosthetic Valve Endocarditis in the ICU CHEST Journal ·Michel Wolff, Serge Witchitz, Claude Chastang, Bernard Regnier, François Vachon	1995	122
14	Intestinal infections in patients with acquired immunodeficiency syndrome Digestive Diseases and Sciences ·Claudie Marche, Bernard Regnier, A. G. Saimot, Jean‐Louis Vildé, C. Perrone, Christophe Michon, Th. Vallot, Françoise Brun‐Vézinet	1989	119
15	Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units Intensive Care Medicine ·Jean‐Christophe Lucet, Xavier Paolettí, Isabelle Lolom, Cathérine Paugam‐Burtz, Jean‐Louis Trouillet, Jean‐François Timsit, Claude Deblangy, Antoine Andremont	2005	119
16	Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit AIDS ·Enrique Casalino, Michel Wolff, Philippe Ravaud, C. Choquet, Fabrice Bruneel, Bernard Regnier	2004	114
17	A multifaceted program to prevent ventilator-associated pneumonia: Impact on compliance with preventive measures* Critical Care Medicine ·Lila Bouadma, Bruno Mourvillier, Véronique Deiler, Bertrand Le Corre, Isabelle Lolom, Bernard Regnier, Michel Wolff, Jean‐Christophe Lucet	2010	112
18	Pneumococcal Meningitis in the Intensive Care Unit: Prognostic Factors of Clinical Outcome in a Series of 80 Cases American Journal of Respiratory and Critical Care Medicine ·Marc Auburtin, Raphaël Porcher, Fabrice Bruneel, Agnès Scanvic, Jean Louis Trouillet, Jean‐Pierre Bédos, Bernard Regnier, Michel Wolff	2002	111
19	Long‐Term Impact of a Multifaceted Prevention Program on Ventilator‐Associated Pneumonia in a Medical Intensive Care Unit Clinical Infectious Diseases ·Lila Bouadma, Emmanuelle Deslandes, Isabelle Lolom, Bertrand Le Corre, Bruno Mourvillier, Bernard Regnier, Raphaël Porcher, Michel Wolff	2010	110
20	Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure Intensive Care Medicine ·Jean‐Ralph Zahar, Élie Azoulay, Elise Klement-Frutos, Arnaud de Lassence, Jean‐Christophe Lucet, Bernard Regnier, Benoı̂t Schlemmer, Jean‐Pierre Bédos	2001	109

About Bernard Regnier

Bernard Regnier is a scholar working on Infectious Diseases, Critical Care and Intensive Care Medicine, Epidemiology, Pharmacology and Applied Microbiology and Biotechnology, having authored 156 papers that have together received 7.4k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (12 papers), Respiratory Support and Mechanisms (12 papers), Nosocomial Infections in ICU (11 papers), Infection Control in Healthcare (11 papers), Hemodynamic Monitoring and Therapy (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Antifungal resistance and susceptibility (9 papers) and Infective Endocarditis Diagnosis and Management (8 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (715 citations), Applied Microbiology and Biotechnology (318 citations), Infectious Diseases (1.6k citations), Molecular Medicine (554 citations) and Epidemiology (1.8k citations). Bernard Regnier has collaborated with scholars based in France, United Kingdom and Spain. Frequent co-authors include Michel Wolff, Sylvie Chevret, Lila Bouadma, Jean M. Carlet, Bertrand Gachot, Jean‐François Timsit, Jean‐Christophe Lucet, Benoît Veber, François Vachon and Fabrice Bruneel. Their work appears in journals such as Intensive Care Medicine, The Lancet, Clinical Infectious Diseases, Critical Care Medicine and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Bernard Regnier

Impact in

Papers in i

In The Last Decade

Bernard Regnier

Bernard Regnier's Hit Papers

Peers

Countries citing papers authored by Bernard Regnier

Fields of papers citing papers by Bernard Regnier

All Works

About Bernard Regnier

Explore authors with similar magnitude of impact

Papers in